Citigroup Maintains Neutral on Qiagen, Lowers Price Target to $38

Benzinga Newsdesk www.benzinga.com Negative 77.1%

Neg 77.1% Neu 0% Pos 0%

Citigroup analyst Patrick Donnelly maintains Qiagen (NYSE:QGEN) with a Neutral and lowers the price target from $55 to $38.